Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Generics Move Slowed By Lack Of Pharmacy Incentives

This article was originally published in PharmAsia News

Executive Summary

Japan's effort to encourage greater use of generic versions of the drugs it covers is being hampered by a resistance by some dispensing pharmacies to promote them. The use of generics instead of higher-priced branded drugs is a centerpiece of the government's effort to lower the national cost of spending on medicines. But critics say that while government changes provided incentives to physicians to prescribe generics, they failed to provide enough economic incentives for pharmacies to follow the policy and substitute generics for brands except when a physician instructs them not to do so. Incentives put into the law fall short of what some experts say is needed to make pharmacies comply. (Click here for more - a subscription may be required

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072198

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel